skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?
Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

Wiechno, Paweł J. ; Sadowska, Małgorzata ; Kalinowski, Tomasz ; Michalski, Wojciech ; Demkow, Tomasz

Psycho-oncology (Chichester, England), 2013-02, Vol.22 (2), p.346-351 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
2
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

Vogelzang, Nicholas J ; Fizazi, Karim ; Burke, John M ; De Wit, Ronald ; Bellmunt, Joaquim ; Hutson, Thomas E ; Crane, Edward ; Berry, William R ; Doner, Kevin ; Hainsworth, John D ; Wiechno, Pawel J ; Liu, Kejian ; Waldman, Michelle F ; Gandhi, Anita ; Barton, Debora ; Jungnelius, Ulf ; Fandi, Abderrahim ; Sternberg, Cora N ; Petrylak, Daniel P

European urology, 2017-02, Vol.71 (2), p.168-171 [Periódico revisado por pares]

Switzerland: Elsevier B.V

Texto completo disponível

Citações Citado por
3
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention
Material Type:
Artigo 		Adicionar ao Meu Espaço

What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention

Poniatowska, Grazyna ; Michalski, Wojciech ; Kucharz, Jakub ; Jonska-Gmyrek, Joanna ; Wieszczy, Paulina ; Nietupski, Karol ; Demkow, Tomasz ; Dedecjus, Marek ; Sadowska, Malgorzata ; Kalinowski, Tomasz ; Grochulska-Nalazek, Beata ; Nowatorska, Ada ; Stelmasiak, Pawel ; Wiechno, Pawel J.

Medical oncology (Northwood, London, England), 2020-09, Vol.37 (9), p.82-82, Article 82 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
Clinical significance of androgen secretion disorders in men with a malignancy
Clinical significance of androgen secretion disorders in men with a malignancy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical significance of androgen secretion disorders in men with a malignancy

Wiechno, Pawel J. ; Poniatowska, Grazyna M. ; Michalski, Wojciech ; Kucharz, Jakub ; Sadowska, Malgorzata ; Jonska-Gmyrek, Joanna ; Nietupski, Karol ; Rzymowska, Joanna ; Demkow, Tomasz

Medical oncology (Northwood, London, England), 2017-07, Vol.34 (7), p.123-123, Article 123 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
5
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor

Wiechno, Paweł J. ; Kowalska, Maria ; Kucharz, Jakub ; Sadowska, Małgorzata ; Michalski, Wojciech ; Poniatowska, Grażyna ; Jońska-Gmyrek, Joanna ; Rzymkowska, Joanna ; Nietupski, Karol ; Demkow, Tomasz

Medical oncology (Northwood, London, England), 2017-05, Vol.34 (5), p.84-84, Article 84 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
6
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post hoc Analysis of the Mainsail Study
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post hoc Analysis of the Mainsail Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post hoc Analysis of the Mainsail Study

de Morrée, Ellen S ; Vogelzang, Nicholas J ; Petrylak, Daniel P ; Budnik, Nikolay ; Wiechno, Pawel J ; Sternberg, Cora N ; Doner, Kevin ; Bellmunt, Joaquim ; Burke, John M ; Ochoa de Olza, Maria ; Choudhury, Ananya ; Gschwend, Juergen E ; Kopyltsov, Evgeny ; Flechon, Aude ; van As, Nicolas ; Houede, Nadine ; Barton, Debora ; Fandi, Abderrahim ; Jungnelius, Ulf ; Li, Shaoyi ; Li, Jack Shiansong ; de Wit, Ronald

JAMA oncology, 2017-01, Vol.3 (1), p.68 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
7
A phase 2 randomized study of oral docetaxel plus ritonavir (ModraDoc006/r) in patients with metastatic castration-resistant prostate cancer (mCRPC)
A phase 2 randomized study of oral docetaxel plus ritonavir (ModraDoc006/r) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 randomized study of oral docetaxel plus ritonavir (ModraDoc006/r) in patients with metastatic castration-resistant prostate cancer (mCRPC)

Vaishampayan, Ulka N. ; Keessen, Marianne ; Heath, Elisabeth I. ; Dreicer, Robert ; Buchler, Tomas ; Árkosy, Péter Ferenc ; Csoszi, Tibor ; Wiechno, Pawel J. ; Kholtobin, Denis ; Kopyltsov, Evgeny ; Shore, Neal D. ; Nosov, Aleander ; Orlov, Sergey ; Plekhanov, Alexey ; Smagina, Maria ; Varlamov, Sergey ; Vogelzang, Nicholas J.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5016-5016 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Phase 2 randomized trial of ModraDoc006/r, oral docetaxel plus ritonavir, versus intravenous docetaxel in metastatic castration resistant prostate cancer (mCRPC)
Phase 2 randomized trial of ModraDoc006/r, oral docetaxel plus ritonavir, versus intravenous docetaxel in metastatic castration resistant prostate cancer (mCRPC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 randomized trial of ModraDoc006/r, oral docetaxel plus ritonavir, versus intravenous docetaxel in metastatic castration resistant prostate cancer (mCRPC)

Vaishampayan, Ulka N. ; Keessen, Marianne ; Shore, Neal D. ; Heath, Elisabeth I. ; Dreicer, Robert ; Buchler, Tomas ; Árkosy, Péter Ferenc ; Csoszi, Tibor ; Wiechno, Pawel J. ; Kopyltsov, Evgeny ; Kholtobin, Denis ; Orlov, Sergey ; Nosov, Aleander ; Varlamov, Sergey ; Vogelzang, Nicholas J.

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.117-117 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone
Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone
Material Type:
Artigo 		Adicionar ao Meu Espaço

Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone

Clarke, Noel W. ; Thiery-Vuillemin, Antoine ; Wiechno, Pawel J. ; Alekseev, Boris ; Sala, Nuria ; Jones, Robert ; Kocak, Ivo ; Chiuri, Vincenzo Emanuele ; Jassem, Jacek ; Flechon, Aude ; Redfern, Charles ; Goessl, Carsten Dietrich ; Burgents, Joseph ; Gresty, Christopher ; Degboe, Arnold ; Saad, Fred

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.234-234 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Olaparib combined with abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A randomized phase II trial
Olaparib combined with abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Olaparib combined with abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A randomized phase II trial

Clarke, Noel ; Wiechno, Pawel J. ; Alekseev, Boris ; Sala, Nuria ; Jones, Robert ; Kocak, Ivo ; Chiuri, Vincenzo Emanuele ; Jassem, Jacek ; Flechon, Aude ; Redfern, Charles ; Goessl, Carsten Dietrich ; Burgents, Joseph ; Kozarski, Robert ; Hodgson, Darren R. ; Saad, Fred

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5003-5003 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (45)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (3)
  2. 2002Até2011  (3)
  3. 2012Até2014  (9)
  4. 2015Até2018  (15)
  5. Após 2018  (17)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.